Dr. John King, M.D

NPI: 1306868856
Total Payments
$63.78
2018 Payments
$46.46
Companies
4
Transactions
4

Payment Breakdown by Category

Food & Beverage$63.78 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $63.78 4 100.0%

Top Paying Companies

Company Total Records Latest Year
Melinta Therapeutics, Inc. $18.59 1 $0 (2018)
AbbVie, Inc. $17.32 1 $0 (2017)
Allergan Inc. $15.91 1 $0 (2018)
Merck Sharp & Dohme Corporation $11.96 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2018 $46.46 3 Melinta Therapeutics, Inc. ($18.59)
2017 $17.32 1 AbbVie, Inc. ($17.32)

All Payment Transactions

4 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
06/18/2018 Melinta Therapeutics, Inc. Baxdela (Drug), Vabomere, Orbactiv Food and Beverage In-kind items and services $18.59 General
Category: INFECTIOUS DISEASES
04/23/2018 Merck Sharp & Dohme Corporation ZERBAXA (Drug), SIVEXTRO Food and Beverage In-kind items and services $11.96 General
Category: INFECTIOUS DISEASE
02/09/2018 Allergan Inc. TEFLARO (Drug) Food and Beverage In-kind items and services $15.91 General
Category: ANTI-INFECTIVE
08/01/2017 AbbVie, Inc. Food and Beverage In-kind items and services $17.32 General

About Dr. John King, M.D

Dr. John King, M.D is a Infectious Disease healthcare provider based in Shreveport, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306868856.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John King, M.D has received a total of $63.78 in payments from pharmaceutical and medical device companies, with $46.46 received in 2018. These payments were reported across 4 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($63.78).

Practice Information

  • Specialty Infectious Disease
  • Location Shreveport, LA
  • Active Since 07/24/2006
  • Last Updated 06/19/2008
  • Taxonomy Code 207RI0200X
  • Entity Type Individual
  • NPI Number 1306868856

Products in Payments

  • Baxdela (Drug) $18.59
  • TEFLARO (Drug) $15.91
  • ZERBAXA (Drug) $11.96

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Infectious Disease Doctors in Shreveport